Top compounds associated with response to SPRR2G


Feature Type Standardized
Nominal ANOVA
mRNA Irinotecan gCSI pan-cancer AAC -0.11 0.03
mRNA TAE684 CCLE pan-cancer AAC -0.097 0.03
mRNA necrostatin-1 CTRPv2 pan-cancer AAC 0.081 0.03
mRNA JQ-1:vorinostat (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.072 0.03
mRNA NSC-87877 GDSC1000 pan-cancer AAC 0.078 0.05
mRNA SZ4TA2 CTRPv2 pan-cancer AAC 0.11 0.05
mRNA AP-24534 GDSC1000 pan-cancer AAC 0.071 0.05
mRNA CP466722 GDSC1000 pan-cancer AAC -0.063 0.05
mRNA Axitinib GDSC1000 pan-cancer AAC 0.075 0.06
mRNA EX-527 CTRPv2 pan-cancer AAC 0.071 0.06
Download CSV